HTG Forms New Drug Discovery Business Unit

NEXT STORY
TRACON Pharmaceuticals Announces Appointment of Brenda Marczi, PharmD, as Senior Vice President, Regulatory Affairs, and Granting of Inducement Award
PREV STORY
SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Checkpoint Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Anti-PD-L1 Antibody Cosibelimab

author_avatar
NASDAQ Market News

Helix BioPharma Corp. and Moffitt Cancer Center extend collaboration on immunotherapy, including study of L-DOS47 with PD-1/PD-L1 inhibitors

RICHMOND HILL, Ontario, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), ...

author_avatar
NASDAQ Market News

AB Science provides the summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis

author_avatar
NASDAQ Market News